The ctDNA for Evaluating Whether to Use Adjuvant Therapy After SBRT in Patients With Early Lung Cancer
Clinical trial NCT05411809 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05411809
- Sponsor
- Peking University Third Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-15
- Primary completion
- 2024-06-15
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.